ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30
ARROWHEAD PHARMACEUTICALS, INC.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$57.23+1.33 (+2.38%)
Close on Oct 19, 2026
- Market cap
- $8.21B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Arrowhead Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 4, 2026 | Aug 4, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 4, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2026 | Jun 16, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 7, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2026 | Mar 20, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2025 | Feb 5, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 5, 2026 | Feb 5, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 26, 2026 | Jan 27, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 6, 2026 | Jan 6, 2026 | SEC EDGAR |
| Annual report | 10-K | Sep 30, 2025 | Nov 25, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 25, 2025 | Nov 25, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2025 | Nov 18, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Sep 30, 2024 | Oct 10, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2025 | Sep 12, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2025 | Sep 11, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2025 | Sep 2, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 11, 2025 | Apr 15, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2025 | Mar 19, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 10, 2025 | Feb 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2024 | Feb 10, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 7, 2025 | Feb 7, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 28, 2025 | Jan 29, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2024 | Dec 18, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 26, 2024 | Nov 26, 2024 | SEC EDGAR |
| Annual report | 10-K | Sep 30, 2024 | Nov 26, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 9, 2024 | May 9, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 9, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 14, 2024 | Mar 19, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 21, 2024 | Feb 22, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2023 | Feb 6, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 6, 2024 | Feb 6, 2024 | SEC EDGAR |